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CsaA from the Gram-positive bacterium Bacillus subtilis has
been identified previously as a suppressor of the growth and
protein-export defect of Escherichia coli secA(Ts) mutants. CsaA
has chaperone-like activities in io and in itro. To examine
the role of CsaA in protein export in B. subtilis, expression of the
csaA gene was repressed. While export of most proteins remained
unaffected, export of at least two proteins was significantly
reduced upon CsaA depletion. CsaA co-immunoprecipitates and
co-purifies with the SecA proteins of E. coli and B. subtilis,
and binds the B. subtilis preprotein prePhoB. Purified CsaA
INTRODUCTION
InEubacteria, proteins can be translocated across the cytoplasmic
membrane and secreted into the medium. These proteins are
usually synthesized as precursors with an N-terminal extension,
the signal peptide (for review, see [1]), which is essential for
directing them into the export pathway (for review, see [2]).
Genetically and biochemically the best-characterized bacterial
export system is that of Escherichia coli (for reviews, see [2,3]).
This system, termed preprotein translocase, consists of the
peripheral membrane protein SecA [4] and a multi-subunit
membrane-protein complex with SecY, SecE and SecG as
subunits [5]. The SecYEG complex acts as a receptor for SecA,
and functions as a preprotein-conducting channel [6,7]. During
or shortly after the translocation of the preprotein across the
membrane, the signal peptide is removed by signal peptidase(s)
(for review, see [8]), a prerequisite for the release of the mature
protein from the membrane [9]. The integral membrane proteins
SecD and SecF [10] are not essential for precursor protein
translocation but, when overproduced, stabilize the SecYEG-
bound SecA in a membrane-inserted state [11].
Whereas bacterial protein translocation is largely uncoupled
from ongoing translation [12], efficient export requires chap-
erones to maintain preproteins in a translocation-competent
state and to target them to the membrane-associated part of the
translocase. In E. coli, SecB is an export-dedicated cytosolic
chaperone that is required for efficient export of a subset of
preproteins [13]. SecB stabilizes preproteins in an unfolded, non-
aggregated state [14], and binds post-translationally or at the late
co-translational stage to the mature region of these proteins [15].
The SecB–preprotein complex is then targeted to the SecYEG-
bound SecA. The preprotein is subsequently transferred from
SecB to SecA, and, upon the ATP-dependent initiation of
translocation, the SecB is released into the cytosol [3]. In io,
only a subset of preproteins appears to be translocated in a SecB-
Abbreviations used: NaPi, inorganic phosphate, NaH2PO4; His6-CsaA, hexa-histidine-tagged CsaA; His6-SecB, hexa-histidine-tagged SecB; His6-
prePhoB, hexa-histidine-tagged prePhoB; IPTG, isopropyl b-D-thiogalactoside ; Ni-NTA, Ni2+-nitrilotriacetate ; SRP, signal recognition peptide.
1 To whom correspondence should be addressed (e-mail jmueller!imb-jena.de).
stimulates the translocation of prePhoB into E. coli membrane
vesicles bearing the B. subtilis translocase, whereas it interferes
with the SecB-mediated translocation of proOmpA into mem-
brane vesicles of E. coli. The specific interaction with the SecA
translocation ATPase and preproteins suggests that CsaA acts as
a chaperone that promotes the export of a subset of preproteins
in B. subtilis.
Key words: chaperone, co-immunoprecipitation, co-purification,
in itro translocation, protein translocation.
dependent manner [2]. A second targeting factor, consisting of
the Ffh protein and the 4.5 S RNA, assists the export of SecB-
independent exported proteins [16]. Other molecular chaperones,
such as the heat-shock proteins DnaK}DnaJ}GrpE [17–19] and
GroEL}GroES [20], appear also to be involved under specific
conditions.
The central components of the protein-translocation system of
B. subtilis are similar to those of E. coli. So far, homologues
of Ffh, 4.5 S RNA, SecA, SecY, SecE, SecG, SecDF and several
type-I signal peptidases have been identified (for review see [21]).
So far, it is unknown if chaperones are involved in protein
translocation in B. subtilis. B. subtilis lacks a SecB homologue
[22] and this has raised the question of whether other chaperones
are involved in protein translocation. Depletion of signal-
recognition-peptide (SRP) components impairs protein trans-
location [23,24], and the B. subtilis Ffh interacts directly with
SecA and promotes the formation of soluble SecA–preprotein
complexes [25]. This has led to the suggestion that SRP of B.
subtilis not only acts as a targeting factor in co-translational
translocation, but also stimulates post-translational translocation
of preproteins [25]. The B. subtilis CsaA protein specifies
chaperone-like activities possibly related to protein translocation
[26]. The csaA gene was identified as a suppressor of growth and
secretion defects of E. coli secA(Ts) strains [27]. Presence of
CsaA stimulated precursor processing in secA, secB, groEL and
dnaJ mutant strains of E. coli and it suppressed the growth
defects of dnaK, dnaJ and grpE mutants of E. coli. CsaA
stimulates the reactivation of heat-denatured firefly luciferase in
groEL, groES, dnaK and grpE mutant strains of E. coli, and
prevents the aggregation of heat-denatured luciferase in itro.
The exact mechanism by which CsaA suppresses the growth and
secretion defects of E. coli secA(Ts) strains is unknown. CsaA
may either improve the translocation-competence of exported
preproteins, thereby making them better substrates for mutant
SecA proteins, or stimulate the translocation activity of the
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mutant SecA proteins. Expression of CsaA in E. coli suppresses
synthesis of SecB [26], whereas an impaired function of general
chaperones causes an elevation in SecB expression [28]. These
data further suggest a chaperone function of CsaA that could
possibly be related to protein translocation.
In this paper we have further examined the role of CsaA in
protein translocation in B. subtilis. CsaA affects the efficient
secretion of some preproteins, and interacts specifically with
SecA and preproteins. The data suggest that CsaA acts as a
chaperone that promotes the export of a subset of preproteins in
B. subtilis.
EXPERIMENTAL
Bacterial strains, plasmids and media
Bacterial strains and plasmids used in this study are listed in
Table 1. Strains were grown in TY medium (Bacto Tryptone}
Bacto Yeast extract) or on TY plates [28]. Pulse labelling of B.
subtilis was carried out in defined HPDM medium [29], casamino
acids were replaced by amino acids (0.02 mg}ml) excluding
methionine and cysteine. If required, ampicillin (80 lg}ml),
erythromycin (5 lg}ml) or kanamycin (20 lg}ml) were added.
Biochemicals
B. subtilis SecA [32], E. coli SecA [33] and the B. subtilis GroELS
complex [34] were isolated from overproducing strains as de-
scribed. proOmpA [7] and hexa-histidine-tagged prePhoB
(His
’
-prePhoB) [35] were purified as described. Purified pro-
OmpA, prePhoB and SecA proteins were labelled with carrier-
free "#&I according to van Wely et al. [35]. Labelled preproteins
were stored frozen in 6 M urea. Polyclonal antiserum was raised
Table 1 Bacterial strains and plasmids, and their genotype/phenotypes
IPTG, isopropyl b-D-thiogalactoside ; His6-CsaA, hexa-histidine-tagged CsaA ; His6-SecB, hexa-
histidine-tagged SecB.
Strain/plasmid Relevant genotype/phenotype Reference
Strains
B. subtilis
DB104 his, nprE, aprE [30]




TG1 hsdD5/F traD36, proA+B+, D(lac-pro) lacIQ,
lacZ DM15
[31]
TG1(pREP4) Host for overexpression of His-tagged proteins This study
TG1(pREP4, pQE9csaA ) TG1 derivative strain, Kmr, Apr, allows IPTG-
inducible synthesis of His6-CsaA
This study
TG1(pREP4, pQE9secB ) TG1 derivative strain, Kmr, Apr, allows IPTG-
inducible synthesis of His6-SecB
This study
Plasmids
pMUTIN2 pBR322-based integration vector for B.
subtilis ; containing IPTG-inducible Pspac
promoter, Apr, Emr
[40]
pMUTINcsaA« pMUTIN2 derivative ; carries the 5« part of
csaA
pREP4 plasmid, containing lacI q repressor gene, Kmr Qiagen
pQE9 pBR322-based vector for IPTG-inducible
synthesis of His6-tagged proteins, Ap
r
Qiagen
pQE9csaA pQE9 derivative plasmid, Apr, allows IPTG-
inducible synthesis of His6-CsaA
This study
pQE9secB TG1 derivative plasmid, Apr, allows IPTG-
inducible synthesis of His6-SecB
This study
against purified hexa-histidine-tagged CsaA (His
’
-CsaA). Anti-
sera against SecA from B. subtilis were from R. Freudl (Fors-
chungszentrum Ju$ lich, Ju$ lich, Germany). Membrane vesicles
were prepared from E. coli strain SF100 [36] containing
plasmid pET605 overproducing SecYEG from E. coli [37]
or plasmid pET822 overproducing SecYEG from B. subtilis
DB104 as described in [38]. Membrane vesicles were treated
with polyclonal antibodies against E. coli SecA to deplete
and inactivate the endogenous SecA [38].
DNA manipulation/techniques
Procedures for DNA purification, restriction, ligation, trans-
formation of E. coli and agarose-gel electrophoresis were carried
out as described bySambrook et al. [39]. The nucleotide sequences
of cloned PCR fragments were confirmed by DNA sequencing.
To amplify csaA«, oligonucleotides 5«-TCTCGAATTCAAT-
AGGAGAAAAAGGAGTT&(%-3«, localized 5« to the ribosome-
binding site of csaA and incorporating an EcoRI re-
striction site, and 5«-GGACCAAGGGATCCGATTTAAAT-
CCGGCG)!&-3«, localized within csaA and incorporating a
BamHI restriction site, were used (the numbers refer to those in
Mu$ ller et al. [27]). The csaA« gene was amplified by PCR from B.
subtilis chromosomal DNA. The amplified fragment was digested
with EcoRI and BamHI and cloned into pMUTIN2 [40]
digested with the same enzymes. The resulting plasmid pMUTIN
csaA« was integrated into the chromosome of B. subtilis DB104
via Campbell-type integration.
For synthesis of His-tagged proteins secB and csaA genes were
amplified excluding their ATG start codons and were inserted 3«
to the His-coding region of pQE9. Genes were amplified by PCR
using oligonucleotides 5«-CACGGATCCGAACAAAACAAC-
ACTG"!$-3«, incorporating a BamHI restriction site, and 5«-
CCGACTGCAGTCATTGAAGCATTACG&&)-3«, with a PstI
restriction site, for secB (the numbers refer to those used in [41]),
and oligonucleotides 5«-GGAGTTATTGGATCCGCAGTTA-
TTGATGAC&*)-3«, with a BamHI restriction site, and 5«-GCC-
GATCTCTGCAGGCCTTTACGGCACACACG*)"-3«, incor-
porating a PstI restriction site, for csaA (the numbers refer to
those used in [27]). PCR fragments were purified, digested with
BamHI and PstI and inserted into pQE9 digested with the same
enzymes. The resulting plasmids pQE9secB and pQE9csaA were
transformed into E. coli TG1(pREP4).
Pulse–chase protein labelling and analysis of protein secretion
Pulse–chase protein-labelling experiments were performed as
described by van Dijl et al. [42]. B. subtilis was grown in minimal
medium to exponential growth in the absence or presence of
1 mM isopropyl b-d-thiogalactoside (IPTG), pulse labelled with
[$&S]methionine for 1 min and subsequently chased. Samples
were taken 2 and 5 min post chase time and proteins secreted into
the growth medium were collected as described in [43]. SDS}
PAGE was performed according to Laemmli [44]. "%C-Meth-
ylated proteins (Amersham International, Amersham, Bucks,
U.K.) were used as molecular-size markers. Relative amounts of
radioactivity were estimated by using a PhosphoImager (Fuji)




-CsaA and hexa-histidine-tagged SecB (His
’
-SecB) were
prepared from IPTG-induced E. coli TG1(pREP4, pQE9csaA)
and TG1(pREP4, pQE9secB) cultures as abundant proteins and
purified by Ni#+-nitrilotriacetate (Ni-NTA) agarose affinity
chromatography. Purification was carried out under native
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conditions following standard protocols (Qiagen, Hilden, Ger-







), pH 8.0, and 300 mM NaCl, were supple-
mented with 10 mM imidazole and applied on to the Ni-NTA
column. The column was washed three times with several column
volumes of NaP
i
buffer containing 20 mM imidazole. His-tagged
proteins were eluted with NaP
i
buffer containing 500 mM
imidazole.
CsaA from B. subtilis was purified immunologically. Affinity-
purified rabbit antibodies against CsaA were covalently linked to
CNBr-activated Sepharose. Exponentially grown B. subtilis
DB104 cells were harvested and extracts were prepared from
lysozyme-treated cells via sonication. Cleared cell extracts were
loaded on to the anti-CsaA–Sepharose column at room tem-
perature. Anti-CsaA–Sepharose was washed with 30 ml of phos-
phate buffer (50 mM, pH 7.0) containing 0.5 M NaCl until no
detectable protein was eluted from the column. CsaA was eluted
with 0.1 M acetic acid, pH 3.0, and subsequently lyophilized. To
obtain SecA-free CsaA B. subtilis cell extracts were purified by
preparative isoelectric focusing in Sephadex gel with a pH
gradient from pH 4.0 to 9.0 for 18 h. After focusing, the Sephadex
gel was cleaved to fractions and CsaA-containing fractions (as
determined immunologically) were analysed by thin-layer poly-
acrylamide gel isoelectric focusing with an ampholyte solution
(pH 3.5–10.0) and SDS}PAGE. The CsaA was precipitated with
ammonium sulphate to a final concentration of 80% saturation.





Proteins isolated from exponentially growing cultures were
assayed by Western blotting [45]. Cell lysates were prepared by
boiling (5 min) in sample buffer and subjecting to SDS}PAGE
[44]. Separated proteins were transferred to a nitrocellulose
membrane (Schleicher & Schu$ ll), as described by Towbin et al.
[45]. CsaA and SecA proteins were detected with specific poly-
clonal antibodies and alkaline phosphatase-conjugated goat anti-
rabbit antibodies (Bio-Rad) according to the manufacturer’s





-prePhoB or ["#&I]SecA to CsaA was
measured as follows: 1 lg of "#&I-labelled protein and 1 lg of
CsaA were incubated at room temperature in 50 ll of Hepes
buffer (50 mM, pH 7.6, additional buffer components as in-
dicated). After 60 min, 5 ll of CsaA-specific antiserum pre-
complexed with 5 mg of Protein A–Sepharose was added and the
mixture was further incubated for 60 min with regular vortexing.
Subsequently, the Protein A–Sepharose beads were washed five
times with 500 ll of Hepes buffer, pH 7.6. "#&I-Labelled proteins
bound to Protein A–Sepharose beads were counted in Optima
Gold scintillation liquid (Packard Instruments B.V., Groningen,
The Netherlands).
Translocation assay
The efficiency of translocation in itro of ["#&I]proOmpA and
["#&I]prePhoB into E. coli membrane vesicles was assayed by
treatment with proteinase K [46]. When indicated, 1.0 lg of
purified E. coli or B. subtilis SecA protein, 2.0 lg of E. coli SecB
or 4 lg of purified B. subtilis GroESL or B. subtilis CsaA were
added. Reactions were started by the addition of 1 ll of "#&I-
labelled precursor protein (0.5 lg of protein). For preincubation
experiments, mixtures were incubated for 30 min at 37 °C without
membrane vesicles prior to the translocation reactions. After
30 min of translocation at 37 °C samples were chilled on ice,
treated with proteinase K (0.5 mg}ml) for 15 min, precipitated
with 7.5% trichloroacetic acid, washed with acetone, dissolved
in SDS}PAGE sample buffer, and analysed by SDS}PAGE
(10% gel) and autoradiography.
RESULTS
Repression of CsaA expression results in alteration of protein
secretion
In B. subtilis strain DB104: :pMUTIN2csaA«, csaA is localized
downstream of the P
spac
promoter, allowing the IPTG-inducible
expression of the CsaA protein. Cells grown in the absence of
IPTG were normally viable but Western-blotting analysis showed
that they contained a dramatically reduced cellular level of CsaA.
Induction of the P
spac
promoter resulted in a production level of
CsaA that was about 2-fold higher than in the wild type (Figure
1A). To study the function of CsaA in protein secretion, the pat-
tern of proteins secreted by B. subtilis DB104: :pMUTIN2csaA«
grown in the absence or presence of IPTG was determined.
While the pattern of secreted proteins of the strain grown in
presence of IPTG was indistinguishable from that of the wild
type, repression of csaA expression resulted in a decrease in
at least two proteins with apparent molecular masses of 19
and 36 kDa (Figure 1B). In particular, the 36-kDa protein
Figure 1 Repression of csaA in B. subtilis affects protein export
(A) B. subtilis strain DB104 (lane 1) and strain DB104 : : pMUTIN2csaA« (lanes 2 and 3) were
grown in TY medium in the absence (lanes 1 and 2) or presence (lane 3) of 1 mM IPTG. Cell
extracts were analysed by SDS/PAGE and Western blotting using CsaA-specific antibodies. (B)
Protein secretion of B. subtilis DB104 : : pMUTIN2csaA« was analysed by pulse labelling of cells
grown in the absence (lanes 1 and 2) or presence (lanes 3 and 4) of IPTG. Secreted proteins
were collected by filtration and analysed by SDS/PAGE and autoradiography.
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Figure 2 E. coli SecA interacts with His6-CsaA and His6-SecB
E. coli strains TG1(pREP4, pQE9csaA) (A, B), TG1(pREP4, pQE9secB) (C) and TG1(pREP4,
pQE9) (D) were cultivated in TY medium to exponential growth and the phage T5 promoter was
derepressed by adding IPTG (final concentration, 2 mM) to the culture medium. After 2 h, cells
were harvested and lysed by sonication, and the cleared cell extracts were loaded on to Ni-NTA
columns. Aliquots of non-bound fraction (FT, lane 1), wash (W1–W3, lanes 2–4) and elution
fractions (E1–E8, lanes 5–12) were analysed by SDS/PAGE and Western blotting using
antibodies directed against CsaA (A) and E. coli SecA (B–D). The asterisk indicates the position
of dimeric CsaA.
seemed completely absent in the supernatant of CsaA-depleted
cells. Both protein bands were isolated from Coomassie Brilliant
Blue-strained SDS}PAGE, and N-terminally sequenced. While
the N-terminus of the 36-kDa protein appeared blocked, the
N-terminus of the 19-kDa protein corresponded to
KENHTFSGED. This amino acid sequence matched the amino
acid residues 33–42 of the precursor of YvaY, a protein with
unknown function and a calculated molecular mass of 18.8 kDa.
E. coli SecA co-purifies with His6-CsaA and His6-SecB
His-tagged CsaA protein was overproduced in E. coli TG1
(pREP4, pQE9csaA) and purified by Ni-NTA-column chroma-
tography. The imidazole-eluted protein fraction predominantly
contained the 13-kDa CsaA protein, and a protein with an
apparent molecular mass of about 30 kDa that stained with
antibodies directed against CsaA (Figure 2A). The latter
probably represents some dimeric CsaA. Immunodetection with
Figure 3 B. subtilis SecA co-purifies with CsaA
A cell lysate of B. subtilis DB104 was loaded on to an anti-CsaA–Sepharose column, washed
with NaCl buffer (0.5 M) and the immunologically bound CsaA was eluted with 0.1 M acetic
acid. The eluate was analysed by SDS/PAGE and Coomassie Brilliant Blue staining (lane 1) or
Western blotting using polyclonal antibodies (pAb) directed against the B. subtilis SecA (lane
2) or CsaA (lane 4). The asterisk indicates the localization of dimeric CsaA. As a control, a lysate
of B. subtilis DB104 : : pMUTIN2csaA« grown in the absence of IPTG was loaded on to the anti-
CsaA–Sepharose column, and the fraction eluted with 0.1 M acetic acid was stained
immunologically with antibodies directed against the B. subtilis SecA (lane 3).
SecA antibodies revealed that SecA co-eluted with CsaA from
the column (Figure 2B). To exclude the possibility that SecA
non-specifically binds to the Ni-NTA resin, a lysate of E. coli
TG1(pREP4) cells that do not express the His-tagged CsaA was
loaded on to an Ni-NTA column (Figure 2D). Under those
conditions, no SecA was retained by the column, suggesting an
interaction between CsaA and SecA. Since SecA is known to
interact with SecB in E. coli [6,7,47], His
’
-SecB was purified from
E. coli TG1(pREP4,pQE9secB) under conditions used for puri-
fication of His
’
-CsaA. SecA was found to co-elute with His
’
-
SecB (Figure 2C). These results indicate that SecA was retained
in the Ni-NTA column via specific binding to His-tagged CsaA
or SecB.
B. subtilis SecA interacts with CsaA
To establish whether the interaction of CsaA with SecA can be
observed in B. subtilis, CsaA was purified from B. subtilis DB104.
Cell extracts were loaded on to an anti-CsaA–Sepharose column,
washed and eluted as described in the Experimental section. The
eluate was analysed by SDS}PAGE and Coomassie Brilliant
Blue staining (Figure 3, lane 1). In addition to CsaA, a protein
co-eluted with an apparent molecular mass of about 90 kDa. The
latter could be immunostained with an antibody directed against
the B. subtilis SecA (Figure 3, lane 2), suggesting that the B.
subtilis SecA associates with CsaA. As a control, a lysate
of B. subtilis DB104: :pMUTIN2csaA« grown in the absence of
IPTG was used. Under those conditions, CsaA was not expressed
(Figure 1A, lane 2) and no SecA was found to bind to the anti-
CsaA–Sepharose column (Figure 3, lane 3).
Since the data in io suggest a specific interaction between
SecA and CsaA, the interaction was examined further using
# 2000 Biochemical Society
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Table 2 Co-immunoprecupitation of CsaA with E. coli and B. subtilis SecA
Purified CsaA and [125I]SecA proteins from E. coli or B. subtilis were mixed in 50 mM Hepes,
pH 7.6, supplemented with 60 mM urea and 1.25% octylglucoside. After 60 min of incubation
at room temperature, CsaA- or E. coli or B. subtilis SecA-specific antibodies pre-complexed with
Protein A–Sepharose were added and the incubation was continued for another 60 min.
Immunoprecipitates were collected by centrifugation and the amount of bound SecA was
quantified by liquid scintillation counting. Amounts of radiolabelled SecA (means‡S.D. from
two independent experiments) are shown in c.p.m. pAb, polyclonal antibody.
Bound [125I]SecA (c.p.m.)
CsaA CsaA pAb SecA pAb E. coli B. subtilis
› › fi 3140‡10 470‡106
› fi fi 948‡470 100‡6
fi › fi 1198‡75 176‡32
fi fi fi 889‡3 139‡5
fi fi › 9724‡100 2170‡15
Table 3 Co-immunoprecupitation of CsaA with B. subtilis prePhoB
Purified CsaA and [125I]His6-prePhoB were mixed in 50 mM Hepes, pH 7.6, supplemented with
60 mM urea and 1.25% octylglucoside. After a 60-min incubation at room temperature, CsaA-
or prePhoB-specific antibodies pre-complexed with Protein A–Sepharose were added and the
incubation was continued for another 60 min. Immunoprecipitates were collected by
centrifugation and the amount of bound prePhoB was quantified by liquid scintillation counting.
pAb, polyclonal antibody.
CsaA CsaA pAb PhoB pAb Bound [125I]PhoB (c.p.m.)
› › fi 1199
› fi fi 75
fi › fi 292
fi fi fi 329
fi fi › 4291
purified proteins. CsaA was co-incubated with "#&I-labelled E.
coli and B. subtilis SecA. Complex formation was analysed by
immunoprecipitation of CsaA. To differentiate between CsaA-
mediated and non-specific binding of SecA to Protein A–
Sepharose, CsaA and}or antiserum against CsaA were excluded
from the reaction mixture. In the presence of CsaA, both the
E. coli and B. subtilis SecA proteins could be immunopre-
cipitated by the CsaA antibodies (Table 2). Background levels of
immunoprecipitation were observed when either CsaA (Table 2)
or the CsaA antibodies were excluded from the reaction
mixture. These results suggest that SecA and CsaA are interacting
proteins.
CsaA binds the preprotein prePhoB and stimulates its
translocation in vitro
CsaA interacts with unfolded proteins [26]. To determine if CsaA
also interacts with unfolded preproteins, urea-denatured B.
subtilis preprotein ["#&I]His
’
-prePhoB at 1 mg}ml was diluted
100-fold into a buffer containing 10 lg}ml CsaA protein. Com-
plex formation was assessed by immunoprecipitation with a
CsaA antibody. A substantial amount of the His
’
-prePhoB could
be co-immunoprecipitated with CsaA (Table 3), whereas only
low levels of prePhoB were immunoprecipitated when either the




-prePhoB was used previously to demonstrate preprotein
translocation into E. coli membrane vesicles derived from a
Figure 4 Effect of CsaA on the SecA-mediated translocation of prePhoB
into membrane vesicles of E. coli containing B. subtilis SecYEG
Translocation of [125I]His6-prePhoB in membrane vesicles was carried out in the absence (lane
1) and presence (lanes 2–6) of exogenous SecA, and the presence of GroELS complex (1 lg,
lane 3) or CsaA (0.5 lg, lane 4 ; 2 lg, lane 5 ; 5 lg, lane 6). After translocation, samples were
treated with proteinase K and analysed by SDS/PAGE and autoradiography. p, precursor ; m,
mature protein.
strain that overexpresses the SecYEG complex of B. subtilis [38].
The ATP-dependent translocation of urea-denatured ["#&I]His
’
-
prePhoB by E. coli membrane vesicles bearing SecYEG and
SecA from B. subtilis was examined using the proteinase digestion
assay. While in the absence of SecA (Figure 4, lane 1) or ATP
(results not shown) hardly any translocation of ["#&I]His
’
-
prePhoB occurred, efficient translocation was observed when the
membrane vesicles were supplemented with purified B. subtilis
SecA (Figure 4, lane 2). Addition of B. subtilis GroESL complex
or increasing amounts of CsaA (Figure 4, lanes 4–6) further
stimulated the translocation of ["#&I]His
’
-prePhoB. To establish
if the stimulatory effect of CsaA is related to maintenance of the
translocation competence of ["#&I]His
’
-prePhoB, experiments
were performed in which ["#&I]His
’
-prePhoB was diluted 50-fold
into buffer in the absence and presence of CsaA, followed by a
30-min precubation at 37 °C. However, under these conditions
prePhoB hardly exhibited a loss in translocation competence
(results not shown), suggesting that CsaA may stimulate trans-
location by another mechanism.
CsaA interferes with SecB for translocation of proOmpA into E.
coli membrane vesicles
Since CsaA interacts with preproteins and with SecA, an activity
reminiscent of SecB, we determined if CsaA is able to substitute
for SecB in the translocation of ["#&I]proOmpA into E. coli
membrane vesicles that contain elevated levels of E. coli SecYEG
complex. Urea-denatured ["#&I]proOmpA was preincubated in
buffer for 30 min in the absence or presence of SecB or CsaA. In
the absence of SecB, the translocation activity of the preincubated
["#&I]proOmpA was largely abolished (Figure 5A, compare lanes
2 and 3). Preincubation of proOmpA with CsaA did not maintain
the translocation competence of proOmpA (Figure 5A, lanes
4–6). Next, the effect of co-incubation of CsaA and SecB with
proOmpA was determined (Figure 5B). The amount of trans-
located ["#&I]proOmpA decreased with the concentration of CsaA
present in the pre-incubation mixture (Figure 5B). When
CsaA was added at the end of the SecB–proOmpA pre-incubation
period, the inhibitory effect of CsaA on the translocation of
["#&I]proOmpA was still evident (Figure 5C). The data indicate
that CsaA interferes with the ability of SecB to promote
proOmpA translocation.
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Figure 5 Translocation of proOmpA by E. colimembrane vesicles containing
overproduced E. coli SecYEG
Translocation of [125I]proOmpA into membrane vesicles was performed as described in the
Experimental section. (A) proOmpA was pre-incubated for 30 min at 37 °C in the absence (lane
1), or presence of SecA (1 lg ; lane 2) and SecB (1 lg ; lane 3) or CsaA (0.1 lg, lane 4 ;
0.5 lg, lane 5 ; 1 lg, lane 6 ; 5 lg, lane 7). (B) proOmpA was pre-incubated for 30 min at
37 °C in the presence of SecA and SecB (1 lg each) and CsaA (0.1 lg, lane 1 ; 0.5 lg, lane
2 ; 1 lg, lane 3 ; 5 lg, lane 4). (C) as (B) except that CsaA was added at the end of the pre-
incubation period. Translocation was assayed after the pre-incubation period by the addition of
membrane vesicles, and was performed as described in the Experimental section. p, precursor ;
m, mature protein.
DISCUSSION
The cytosolic B. subtilis protein CsaA has been identified as a
suppressor of E. coli secA mutations [26]. CsaA has chaperone-
like activities both in io and in itro [26]. We have now studied
the role of CsaA in protein translocation in B. subtilis using an
in itro translocation system [35,38]. The data indicate that CsaA
is able to interact with the B. subtilis preprotein prePhoB and the
translocation ATPase SecA, and that this interaction results in a
stimulation of prePhoB translocation. Moreover, repression of
the csaA gene in B. subtilis results in a reduction of the secretion
efficiency of at least two proteins. Such interactions are remi-
niscent of the secretion-dedicated function of the molecular
chaperone SecB in E. coli [15]. Since B. subtilis lacks a protein
homologous to SecB [22], CsaA may fulfil a similar function for
a specific subset of preproteins to the E. coli SecB.
As a heterologous component, CsaA suppresses export and
chaperone defects in E. coli [26,27]. To study the function of
CsaA in protein export in B. subtilis, protein export was analysed
in response to csaA suppression. Earlier extensive gene-disruption
experiments failed [27], suggesting that csaA is an essential gene
of B. subtilis. Therefore, csaA was placed under transcriptional
control of the P
spac
promoter using the integrative plasmid
pMUTIN2 [40]. Despite the fact that CsaA could not be detected
in the absence of IPTG (Figure 1A), no alteration of growth was
observed for B. subtilis DB104: :pMUTIN2csaA« when grown in
complex or defined medium. The possibility that minimal ex-
pression of CsaA, beyond the detection limit, suffices to sustain
growth of this strain in the absence of IPTG cannot be excluded.
Whereas in the presence of IPTG, protein secretion was essen-
tially similar to the parental strain, repression of csaA resulted
in a reduced export of at least two proteins at the end of
the exponential growth phase.
An interaction between CsaA and E. coli or B. subtilis SecA
could be demonstrated by various techniques. E. coli SecA co-
purifies with His
’
-tagged CsaA on an Ni-NTA affinity resin, while
the B. subtilis SecA was found to specifically co-purify with CsaA
by means of an immuno-purification technique. Likewise, E. coli
SecA co-purifies with His
’
-SecB using the Ni-NTA-affinity
column-chromatography technique. Since the latter interaction
has been established previously [6], it suggests that the
CsaA–SecA complex is also stable. No other proteins were co-
purified in detectable amounts. The markedly lower retention of
SecA in the presence of His
’
-CsaA compared with the retention
by His
’
-SecB might have been due to the heterologous character
of CsaA when expressed in E. coli. The interaction between CsaA
and SecA could be demonstrated further in itro by a co-
immunoprecipitation of "#&I-labelled purified proteins. In E.
coli, SecB binds to a well-conserved C-terminal region of SecA
[7]. When fused to glutathione S-transferase, the 20 C-terminal
amino acids of E. coli SecA represent an authentic SecB-binding
domain. This glutathione S-transferase-fusion protein, however,
does not interact with CsaA (J. P. Mu$ ller, J. Swaving, K. H. M.
van Wely and A. J. M. Driessen, unpublished work), indicating
that other domains of SecA are involved in this binding reaction.
Interaction of CsaA with unfolded preproteins could be demon-
strated by co-immunoprecipitation of His
’
-prePhoB via CsaA.
Similar experiments with radiolabelled proOmpA suggest that
CsaA also interacts with this precursor (J. P. Mu$ ller, J. Swaving,
K. H. M. van Wely and A. J. M. Driessen, unpublished work).
Interaction of CsaA with these unfolded precursors is not
unexpected since CsaA can also interact with other unfolded
proteins [26].
The exact mechanism of suppression of impaired activity of
the temperature-sensitive SecA proteins has not yet been es-
tablished. CsaA may act by improving the translocation-com-
petence of exported preproteins, thereby making them better
substrates for the malfunctioning SecA proteins, or it may act
directly on the activity of SecA [25]. Our current data suggest
that it may stimulate translocation by improving the targeting to
SecA as it binds SecA specifically.
In E. coli, chaperones are needed to support translocation of
preproteins in itro. SecB is required for a subset of preproteins
[14,48], while other chaperones such as GroES}GroEL or
DnaK}DnaJ}GrpE support translocation under certain con-
ditions only [49]. In B. subtilis, no chaperones have thus far been
found that stimulate preprotein translocation, although this
function may be fulfilled by SRP, which has been shown to
interact with SecA, thereby promoting the formation of soluble
SecA–preprotein complexes [24]. Here we have shown that CsaA
stimulates the translocation in itro of prePhoB into membrane
vesicles by about 2–3-fold. It is important to note that prePhoB
only slowly loses its translocation competence when diluted from
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urea, suggesting that the stimulation is due to targeting. More
striking is the observation that CsaA competes with SecB for
proOmpA translocation. When proOmpA is preincubated with a
mixture of SecB and CsaA, SecB is no longer able to stimulate
the translocation of proOmpA. In this context, it is important to
note that CsaA itself does not stimulate the translocation of
proOmpA, nor is it able to maintain the translocation competence
of proOmpA. Since the inhibitory effect of CsaA is less pro-
nounced when proOmpA is first pre-incubated with SecB, it
seems that competition is mainly at the level of binding of the
precursor, thus preventing SecB to target proOmpA to the
translocation sites while maintaining its translocation compe-
tence. Elucidation of the mechanism of inhibition may provide
further insight into the function of CsaA.
Taken together, the results in io and in itro indicate that
CsaA is able to bind to both B. subtilis preproteins and the SecA
translocation ATPase, suggesting an export-related function of
CsaA in B. subtilis. Depletion of CsaA in B. subtilis gives rise to
an export defect of a set of proteins. Analysis of the translocation
of these proteins in B. subtilis will further define the function of
CsaA in protein secretion.
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